The Sonic Hedgehog (SHH) morphogen pathway is fundamental for embryonic development and stem cell maintenance and is implicated in various cancers. A key step in signaling is transfer of a palmitate group to the SHH N terminus, catalyzed by the multi-pass transmembrane enzyme Hedgehog acyltransferase (HHAT). We present the high-resolution cryo-EM structure of HHAT bound to substrate analog palmityl-coenzyme A and a SHH-mimetic megabody, revealing a heme group bound to HHAT that is essential for HHAT function. A structure of HHAT bound to potent small-molecule inhibitor IMP-1575 revealed conformational changes in the active site that occlude substrate binding. Our multidisciplinary analysis provides a detailed view of the mechanism by which HHAT adapts the membrane environment to transfer an acyl chain across the endoplasmic reticulum membrane. This structure of a membrane-bound O-acyltransferase (MBOAT) superfamily member provides a blueprint for other protein-substrate MBOATs and a template for future drug discovery.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693861 | PMC |
| http://dx.doi.org/10.1016/j.molcel.2021.11.018 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Desert Hedgehog Down-regulation Mediates Inhibition of Proliferation by γ-Glutamylcyclotransferase Knockdown in Murine Glioblastoma Stem Cells.
Cancer Genomics Proteomics
August 2024
Laboratory of Clinical Oncology, Kyoto Pharmaceutical University, Kyoto, Japan;
Background/aim: Glioblastoma is the most frequent type of adult-onset malignant brain tumor and has a very poor prognosis. Glioblastoma stem cells have been shown to be one of the mechanisms by which glioblastoma acquires therapy resistance. Therefore, there is a need to establish novel therapeutic strategies useful for inhibiting this cell population.
View Article and Find Full Text PDFThe Pseudo-Natural Product Tafbromin Selectively Targets the TAF1 Bromodomain 2.
Angew Chem Int Ed Engl
August 2024
Max-Planck Institute of Molecular Physiology, Department of Chemical Biology, Otto-Hahn-Strasse 11, Dortmund, 44227, Germany.
Article Synopsis
- Phenotypic assays are valuable for detecting small molecules that influence cellular functions and can reveal new target interactions and biological insights.
- An osteoblast differentiation assay using a Hedgehog signaling agonist identified a class of osteogenesis inhibitors known as pyrrolo[3,4-g]quinoline (PQ) compounds.
- The most effective compound, Tafbromin, disrupts Hedgehog signaling by binding to TAF1's bromodomain 2, making it a promising resource for exploring biological processes related to TAF1(bromodomain 2).
Low MBOAT7 expression, a genetic risk for MASH, promotes a profibrotic pathway involving hepatocyte TAZ upregulation.
Hepatology
February 2025
Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Article Synopsis
- - The genetic variant rs641738 C>T is linked to metabolic dysfunction-associated steatotic liver disease (MASH) and is associated with reduced levels of the enzyme MBOAT7, which is important for phospholipid remodeling, impacting liver health and fibrosis levels.
- - Research on mice showed that restoring MBOAT7 expression helps slow liver fibrosis progression, while silencing it worsens fibrosis despite not affecting fat accumulation in the liver; this is connected to TAZ, a protein that promotes fibrosis.
- - The study concluded that loss of MBOAT7 leads to changes in liver phospholipids that activate TAZ and increase a profibrotic factor, suggesting a potential for personalized medicine targeting TAZ to
Design, Synthesis, and Evaluation of Inhibitors of Hedgehog Acyltransferase.
J Med Chem
January 2024
Department of Chemistry, Imperial College London, London W12 0BZ, U.K.
Hedgehog signaling is involved in embryonic development and cancer growth. Functional activity of secreted Hedgehog signaling proteins is dependent on -terminal palmitoylation, making the palmitoyl transferase Hedgehog acyltransferase (HHAT), a potential drug target and a series of 4,5,6,7-tetrahydrothieno[3,2-]pyridines have been identified as HHAT inhibitors. Based on structural data, we designed and synthesized 37 new analogues which we profiled alongside 13 previously reported analogues in enzymatic and cellular assays.
View Article and Find Full Text PDFNAA10 overexpression dictates distinct epigenetic, genetic, and clinicopathological characteristics in adult gliomas.
J Neuropathol Exp Neurol
June 2023
Department of Pathology, University of Yamanashi, Yamanashi, Japan.
NAA10 is a novel biomarker of cancer progression. The oncogenic and biological mechanisms of NAA10 in human malignancies are controversial and remain to be elucidated. Herein, we investigated the biological and clinicopathological implications of NAA10 gene expression in adult gliomas.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!